The global clinical trials supply & logistics market size is expected to reach USD 6.25 billion by 2030, registering a CAGR of 7.6% from 2024 to 2030, according to a new report by Grand View Research, Inc. The rise in advanced technology and innovations in the clinical trial supply & logistics market, implementation of stringent regulations, and the rising demand for clinical trials due to the increasing prevalence of diseases such as the COVID-19 pandemic.
Initially, the COVID-19 pandemic negatively impacted the market due to disruption in the supply chain and a reduction in commercial airlines by the government to prevent the spread of the virus. However, the market soon recovered and started to grow significantly due to rising demand for the COVID-19 vaccine to prevent this disease. For instance, according to WHO, as of August 2, 2022, there are 169 vaccines in the clinical development stage and 198 vaccines in the preclinical phase.
There has been significant investment in supply chain management software by clinical trial supplies providers. Growing complexity in clinical trials and increased competition among market players are factors responsible for the adoption of new technologies in supply chain management. The need for software for inventory management, supply chain planning, and ancillary supply chain management is expected to grow, owing to the increasing adoption of new technologies by industry players.
Request a free sample copy or view report summary: Clinical Trials Supply & Logistics Market Report
In service segment, logistics & distribution dominated the market in 2023 with a share of 25.33%. This is due to the rise in clinical trials due to COVID- 19 pandemic
Based on phase, The phase III segment accounted for the largest revenue share in 2023
Based on therapeutic area, cardiovascular diseases accounted for the fastest CAGR of 8.0% during the forecast period. This is due to the rise in the number of investments by market players for bringing novel and innovation to the market
Asia Pacific is anticipated to register the fastest growth rate of 8.1% during the forecast period. This is due to low recruitment cost, region has access to a large and diversified patient pool, and favorable policies that make the region desirable for clinical trials
Grand View Research has segmented the global clinical trials supply & logistics market on the basis of service, phase, therapeutic area, end-use, and region:
Clinical Trials Supply & Logistics Service Outlook (Revenue, USD Million, 2018 - 2030)
Logistics & Distribution
Storage & Retention
Packaging, Labeling, And Blinding
Manufacturing
Comparator Sourcing
Other Services
Clinical Trials Supply & Logistics Phase Outlook (Revenue, USD Million, 2018 - 2030)
Phase I
Phase II
Phase III
Phase IV
Clinical Trials Supply & Logistics Therapeutic Area Outlook (Revenue, USD Million, 2018 - 2030)
Oncology
Cardiovascular Diseases
Respiratory Diseases
CNS And Mental Disorders
Others
Clinical Trials Supply & Logistics End-use Outlook (Revenue, USD Million, 2018 - 2030)
Pharmaceuticals
Biologicals
Medical Devices
Clinical Trials Supply & Logistics Regional Outlook (Revenue, USD Million, 2018 - 2030)
North America
U.S.
Canada
Europe
UK
Germany
France
Italy
Spain
Denmark
Sweden
Norway
Asia Pacific
Japan
China
India
South Korea
Australia
Thailand
Latin America
Brazil
Mexico
Argentina
Middle East & Africa
South Africa
Saudi Arabia
UAE
Kuwait
List of Key Players in the Clinical Trials Supply & Logistics Market
Thermo Fisher Scientific (Patheon)
Catalent, Inc.
Parexel International (MA) Corporation
Almac Group
Marken
Piramal Pharma Solutions
UDG Healthcare
DHL
FedEx
Movianto
Packaging Coordinators Inc
"The quality of research they have done for us has been excellent..."